Bay Rivers Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Bay Rivers Group's AMGN Position: Q2 2026 in Review
Bay Rivers Group increased its Amgen (AMGN) stake by 3.9% in Q2 2026, buying an estimated $115K and bringing the position to 8,944 shares worth $3.24M. The position accounts for 1.11% of the portfolio, ranked #27.
Bay Rivers Group first reported a position in AMGN in Q4 2019 and has held it in 27 quarters since. 1,487 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Bay Rivers Group held 8,944 shares of Amgen worth $3.24M as of Q2 2026.
- Bay Rivers Group bought 337 Amgen shares in Q2 2026, an estimated $115K.
- Amgen made up 1.11% of Bay Rivers Group's portfolio in Q2 2026, its #27 holding.
- Bay Rivers Group first reported a position in Amgen in Q4 2019 and has held it in 27 quarters since.
- 1,487 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Bay Rivers Group's 13F filing for Q2 2026, filed 9 Jul 2026.